EMA to reveal more marketing authorisation data
On 1 March it will release international non-proprietary names (INN)
The European Medicines Agency (EMA) will from 1 March publish information on applications for EU pharmaceutical marketing authorisations. It will release international non-proprietary names (INN); therapeutic targets for innovative medicines; and data on types of salt, esters or derivatives of active substances.
For generic and biosimilar medicines, it will publish INNs and therapeutic targets.